Filing Details
- Accession Number:
- 0001209191-21-021219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-16 21:49:51
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-16 21:49:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1718852 | Prometheus Biosciences Inc. | RXDX | Pharmaceutical Preparations (2834) | 814282653 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1734751 | Mark Stenhouse | C/O Prometheus Biosciences, Inc. 9410 Carroll Park Drive San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-16 | 14,000 | $19.00 | 14,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
